LatchBio provides white-labeled data infrastructure, analysis tools and delivery portals for biotech solution providers. In collaboration with Miraomics and Pythia, the company released a 30 million cell atlas spanning 150 diseases, 200 tissues, and 27 technologies available for immediate access on a usage basis. The company also released an agentric AI curation framework used to […]

In the study of rare diseases and precision medicine, understanding gene expression in the spatial context of tissues is essential. High-throughput sequencing and STOmics technology will enhance biological and molecular understanding of various pathologies. MILAN — MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced a […]

FREMONT, Calif. — Ultima Genomics, a developer of an innovative new ultra-high throughput sequencing architecture, today announced that its UG 100 ™ sequencing platform has been selected to support Regeneron Genetics Center® (RGC™) and its recently launched U.S. large-scale proteomics study. The study, comprised of 200,000 blood serum samples secured by RGC from its long-standing research collaboration with Geisinger Health System, will be […]

Autonomous Ground Security Robots with Real-Time Gas Detection Deployed to Safeguard the World’s Largest Single-Day Sporting Event NORRISTOWN, Pa. — Asylon, the U.S. leader in robotic security solutions, in collaboration with 908 Devices, the Indianapolis Metropolitan Police Department, and the Indianapolis Motor Speedway, returned to this year’s Indianapolis 500 to deploy its gas-sniffing security robots to […]

Researchers aim to understand mechanisms of alternative splicing in neurodegenerative disease SEATTLE, United States — Parse Biosciences today announced their commitment to support researchers from the Icahn School of Medicine at Mount Sinai in generating one of the largest single cell datasets focused on understanding alternative splicing events in the cells of Alzheimer’s and Parkinson’s […]

Peachtree Corners, GA – RayBiotech Life, Inc., a global leader in proteomics and translational research tools, is proud to announce a new strategic collaboration with Venebio Group, LLC, a premier life sciences consultancy renowned for its expertise in regulatory strategy and drug safety analytics. Under the newly executed Master Services Agreement (MSA), the two companies will […]

Strategic collaboration to innovate Treg and TIL therapies, streamline cell therapy workflows, and enhance manufacturing efficiency SAN FRANCISCO — Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, to advance research in regulatory […]

DENVER, CO – Exum Instruments Inc., Colorado-based manufacturer of analytical instruments that increase the speed of development and discovery, is excited to announce a distribution partnership with Thermo Fisher Scientific Inc., a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, and laboratory services. This collaboration combines Exum’s groundbreaking technology, Massbox®, with Thermo Fisher […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that enables the Company to sell USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) reference standards with its analytical solutions, including the Maurice system, to support monoclonal antibody and gene therapy development around the world. More than 160 antibody […]

BRANFORD, Conn. — Jun. 24, 2025– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the placement of its Platinum® Pro instrument at the Broad Institute. This collaboration aims to support scientific innovation across oncology, therapeutics, and other key areas of biomedical research. This placement expands […]